G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $55,000 | -40.2% | 11,220 | -7.7% | 0.06% | -23.7% |
| Q1 2022 | $92,000 | -78.3% | 12,152 | -70.7% | 0.08% | -77.7% |
| Q4 2021 | $424,000 | -49.8% | 41,480 | -34.1% | 0.34% | -48.2% |
| Q3 2021 | $844,000 | -35.7% | 62,912 | +5.2% | 0.66% | -34.5% |
| Q2 2021 | $1,312,000 | -6.1% | 59,814 | +3.0% | 1.00% | -16.7% |
| Q1 2021 | $1,397,000 | +112.6% | 58,064 | +59.0% | 1.20% | +97.2% |
| Q4 2020 | $657,000 | – | 36,526 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |